TABLE 7.

Clinical success rate at test of cure in patients with and without serologic evidence of atypical pathogens at screeninga

GroupNo. of successes/no. in group (% successes) in amoxicillin-clavulanate treatment group:
2,000/125 mg875/125 mg
Clinical PP test of cure population247226
    Group A (at least one typical pathogen) (groups B and C combined)63/70 (90.0)43/52 (82.7)
    Group B (typical pathogen only)37/43 (86.0)31/35 (88.6)
    Group C (typical and atypical pathogens)26/27 (96.3)12/17 (70.6)
    Group D (atypical pathogen only)43/47 (91.5)56/63 (88.9)
    Group E (at least one atypical pathogen) (groups C and D combined)69/74 (93.2)68/80 (85.0)
ITT population322311
    Group A (at least one typical pathogen) (groups B and C combined)78/87 (89.7)53/73 (72.6)
    Group B (typical pathogen only)50/58 (86.2)39/52 (75.0)
    Group C (typical and atypical pathogens)28/29 (96.6)14/21 (66.7)
    Group D (atypical pathogen only)54/61 (88.5)71/82 (86.6)
    Group E (at least one atypical pathogen) (groups C and D combined)82/90 (91.1)85/103 (82.5)
  • a See Table 3, footnote a.